The Valley Desk

NCT03440385 · Interventional trial

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Overall registry status Completed

Phase 3

Conditions Crohn Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov